Anzeige
Mehr »
Login
Freitag, 10.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DWNW | ISIN: SE0019071812 | Ticker-Symbol: P750
München
10.05.24
08:15 Uhr
0,013 Euro
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
PERPETUA MEDICAL AB Chart 1 Jahr
5-Tage-Chart
PERPETUA MEDICAL AB 5-Tage-Chart

Aktuelle News zur PERPETUA MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
24.04.Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) appoints Camilla Lönn as CFO6
23.04.Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) announces its first day of trading on Nasdaq First North under its new company name2
22.04.Nasdaq Stockholm AB: Change of company name: Pharmacolog i Uppsala AB (publ) changes name to Perpetua Medical AB (publ)180As from April 23, 2024, Pharmacolog i Uppsala AB (publ)will change company name to Perpetua Medical AB (publ). ISIN Code will not change. Old company name: Pharmacolog i Uppsala AB (publ) ---------------------------------------------------- New...
► Artikel lesen
17.04.Nolsterby Invest AB has increased its holding further in Pharmacolog1
16.04.ANNOUNCEMENT FROM THE EXTRAORDINARY GENERAL MEETING OF PHARMACOLOG I UPPSALA AB ON APRIL 16, 20242
16.04.Pharmacolog publishes annual report for 20231
15.04.Nasdaq Stockholm AB: The observation status for Pharmacolog i Uppsala AB (publ) is removed184On October 13, 2023, the financial instruments of Pharmacolog i Uppsala AB (publ) (the "Company") were given observation status with reference to substantial uncertainty regarding the issuer or the...
► Artikel lesen
08.04.Nolsterby Invest AB has increased its holding in Pharmacolog1
04.04.Pharmacolog announces the appointment of Anders Hedlund as interim CEO1
14.03.NOTICE TO EXTRAORDINARY GENERAL MEETING IN PHARMACOLOG I UPPSALA AB (PUBL)1
14.03.Pharmacolog provides update on new business direction and proposes name change2
01.03.Pharmacolog announces upcoming change in management1
27.02.Warrants of series TO3 were subscribed to approximately 90.4 percent and Pharmacolog receives approximately SEK 2.3 million1
20.02.Major shareholder in Pharmacolog exercises warrants of series TO3 for at least approximately SEK 0.54 million-
20.02.The last day of trading with warrants of series TO3 in Pharmacolog is today, February 20, 20241
16.02.Year-end bulletin Pharmacolog 20231
15.02.Pharmacolog investigates the possibilities for a new business direction2
14.02.Pharmacolog terminates the partnership agreement with Codonics with immediate effect2
09.02.RAYSEARCH LABORATORIES: RaySearch acquires the product DrugLog from Pharmacolog for chemotherapy quality assurance-
09.02.Pharmacolog divests part of its operations to RaySearch Laboratories AB2
Seite:  Weiter >>
34 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1